A randomized cross-over trial on the direct effects of oxygen supplementation therapy using different devices on cycle endurance in hypoxemic patients with interstitial lung disease

PLoS ONE

Volumn 13, Issue 12, 2018, Pages

  Edvardsen, Anne ^a   Jarosch, Inga ^b   Grongstad, Anita ^a   Wiegand, Laura ^c   Gloeckl, Rainer ^b,d   Kenn, Klaus ^b,c   Spruit, Martijn A ^e,f,g  

^a LHL Hospital Gardermoen   (Norway)

^b Schoen Klinik Berchtesgadener Land   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e CIRO+   (Netherlands)

^f HASSELT UNIVERSITY   (Belgium)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARBON DIOXIDE TENSION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DYSPNEA; ENDURANCE TRAINING; FEMALE; FLOW RATE; HEART RATE; HUMAN; HYPOXEMIA; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION; MALE; OXYGEN SATURATION; OXYGEN TENSION; OXYGEN THERAPY; RANDOMIZED CONTROLLED TRIAL; AGED; COMPLICATION; DEVICES; EXERCISE TEST; EXERCISE TOLERANCE; MIDDLE AGED; OXYGEN CONSUMPTION; PATHOLOGY; PROCEDURES;

OXYGEN DERIVATIVE;

AGED; CROSS-OVER STUDIES; DYSPNEA; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART RATE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; OXYGEN COMPOUNDS; OXYGEN CONSUMPTION; OXYGEN INHALATION THERAPY;

EID: 85059234671     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0209069     Document Type: Article

References (30)

1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. on behalf of the ATS/ERS/JRS/ ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Resp Crit Care Med 2011; 183(6):788-824. https://doi.org/10.1164/rccm.2009-040GL PMID: 21471066
2. Holland AE. Exercise limitation in interstitial lung disease-mechanisms, significance and therapeutic options. Chron Respir Dis 2010; 7(2):101-11. https://doi.org/10.1177/1479972309354689 PMID: 20056733
3. Ryerson CJ, Donesky D, Pantilat SZ, Collard HR. Dyspnea in idiopathic pulmonary fibrosis: a systematic review. J Pain Symptom Manage 2012; 43(4):771-82. https://doi.org/10.1016/j.jpainsymman.2011.04.026 PMID: 22285287
4. Miki K, Maekura R, Hiraga T, Okuda Y, Okamoto T, Hirotani A, et al. Impairments and prognostic factors for survival in patients with idiopathic pulmonary fibrosis. Respir Med 2003; 97(5):482-90. PMID: 12735664
5. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Resp Crit Care Med 2003; 168 (9):1084-90. https://doi.org/10.1164/rccm.200302-219OC PMID: 12917227
6. Flaherty KR, Andrei AC, Murray S, Fraley C, Colby TV, Travis WD, et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Resp Crit Care Med 2006; 174(7):803-9. https://doi.org/10.1164/rccm.200604-488OC PMID: 16825656
7. Hardinge M, Annandale J, Bourne S, Cooper B, Evans A, Freeman D, et al. British Thoracic Society guidelines for home oxygen use in adults. Thorax 2015; 70 Suppl 1:i1-43.
8. Kenn K, Gloeckl R, Behr J. Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis-a review. Respiration 2013; 86(2):89-99. https://doi.org/10.1159/000354112 PMID: 23942353
9. Harris-Eze AO, Sridhar G, Clemens RE, Gallagher CG, Marciniuk DD. Oxygen improves maximal exercise performance in interstitial lung disease. Am J Resp Crit Care Med 1994; 150(6):1616-22.
10. Bye PT, Anderson SD, Woolcock AJ, Young IH, Alison JA. Bicycle endurance performance of patients with interstitial lung disease breathing air and oxygen. Am Rev Respir Dis 1982; 126(6):1005-12. https://doi.org/10.1164/arrd.1982.126.6.1005 PMID: 7181219
11. Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63 Suppl 5:v1-58.
12. Sharp C, Adamali H, Millar AB. Ambulatory and short-burst oxygen for interstitial lung disease. The Cochrane database of systematic reviews 2016; 7:CD011716. https://doi.org/10.1002/14651858.CD011716.pub2 PMID: 27383922
13. Tiep BL, Nicotra B, Carter R, Belman MJ, Mittman C. Evaluation of a low-flow oxygen-conserving nasal cannula. Am Rev Respir Dis 1984; 130(3):500-2. https://doi.org/10.1164/arrd.1984.130.3.500 PMID: 6476597
14. Dumont CP, Tiep BL. Using a reservoir nasal cannula in acute care. Crit Care Nurse 2002; 22(4):41-6. PMID: 12166054
15. Carter R, Williams JS, Berry J, Peavler M, Griner D, Tiep B. Evaluation of the pendant oxygen-conserving nasal cannula during exercise. Chest 1986; 89(6):806-10. PMID: 3709245
16. Evans TW, Waterhouse JC, Suggett AJ, Howard P. A conservation device for oxygen therapy in COPD. Eur Respir J 1988; 1(10):959-61. PMID: 3147198
17. Arlati S, Rolo J, Micallef E, Sacerdoti C, Brambilla I. A reservoir nasal cannula improves protection given by oxygen during muscular exercise in COPD. Chest 1988; 93(6):1165-9. PMID: 3371094
18. Gloeckl R, Heinzelmann I, Matthaei M, Seeberg S, Damisch T, Jerrentrup A, et al. Benefits of an oxygen reservoir cannula versus a conventional nasal cannula during exercise in hypoxemic COPD patients: a crossover trial. Respiration 2014; 88(5):399-405. https://doi.org/10.1159/000368165 PMID: 25323335
19. Collard P, Wautelet F, Delwiche JP, Prignot J, Dubois P. Improvement of oxygen delivery in severe hypoxaemia by a reservoir cannula. Eur Respir J 1989; 2(8):778-81. PMID: 2806500
20. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Resp Crit Care Med 2002; 165(2):277-304. https://doi.org/10.1164/ajrccm.165.2.ats01 PMID: 11790668
21. Gloeckl R, Halle M, Kenn K. Interval versus continuous training in lung transplant candidates: a randomized trial. J Heart Lung Transplant 2012; 31(9):934-41. https://doi.org/10.1016/j.healun.2012.06.004PMID: 22884381
22. Ross RM. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Resp Crit Care Med 2003; 167(10):1451 https://doi.org/10.1164/ajrccm.167.10.950 PMID: 12738602
23. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14(5):377-81. PMID: 7154893
24. Casaburi R. Factors Determining Constant Work Rate Exercise Tolerance in COPD and their Role in Dictating the Minimal Clinically Important Difference in Response to Interventions. COPD: J Chron Obstr Pulm Dis 2005; 2(1):131-6.
25. Nishiyama O, Miyajima H, Fukai Y, Yamazaki R, Satoh R, Yamagata T, et al. Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia. Respir Med 2013; 107(8):1241-6. https://doi.org/10.1016/j.rmed.2013.05.015 PMID: 23806287
26. Visca D, Montgomery A, de Lauretis A, Sestini P, Soteriou H, Maher TM, et al. Ambulatory oxygen in interstitial lung disease. Eur Respir J 2011; 38(4):987-90. https://doi.org/10.1183/09031936.00190710PMID: 21965506
27. Frank RC, Hicks S, Duck AM, Spencer L, Leonard CT, Barnett E. Ambulatory oxygen in idiopathic pulmonary fibrosis: of what benefit? Eur Respir J 2012; 40(1):269-70. https://doi.org/10.1183/09031936. 00007712 PMID: 22753837
28. Marti S, Pajares V, Morante F, Ramon MA, Lara J, Ferrer J, Guell MR. Are oxygen-conserving devices effective for correcting exercise hypoxemia? Respir Care 2013; 58(10):1606-13. https://doi.org/10.4187/respcare.02260 PMID: 23513249
29. Christensen CC, Ryg MS, Edvardsen A, Skjønsberg OH. Effect of exercise mode on oxygen uptake and blood gases in COPD patients. Respir Med 2004; 98(7):656-60. PMID: 15250232
30. Claiborne RA, Paynter DE, Dutt AK, Rowlands JW. Evaluation of the use of an oxygen conservation device in long-term oxygen therapy. Am Rev Respir Dis 1987; 136(5):1095-8. https://doi.org/10.1164/ajrccm/136.5.1095 PMID: 3674570